Lb Pharmaceuticals (LBRX) Other Accumulated Expenses (2024 - 2026)

Lb Pharmaceuticals' Other Accumulated Expenses history runs 3 years deep, the most recent figure standing at $132000.0 for Q1 2026.

• In Q1 2026, Other Accumulated Expenses changed N/A year-over-year to $132000.0; the TTM figure through Mar 2026 stood at $132000.0 (changed N/A YoY), while the FY2025 annual figure was $267000.0, up 17.11% from the prior year.
• Other Accumulated Expenses was $132000.0 for Q1 2026 at Lb Pharmaceuticals, down from $267000.0 in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $267000.0 in Q4 2025 to a low of $132000.0 in Q1 2026.
• Historically, Other Accumulated Expenses has averaged $207000.0 across 3 years, with a median of $214500.0 in 2024.
• Biggest YoY gain for Other Accumulated Expenses was 17.11% in 2025; the steepest drop was 17.11% in 2025.
• A 3-year view of Other Accumulated Expenses shows it stood at $228000.0 in 2024, then gained by 17.11% to $267000.0 in 2025, then tumbled by 50.56% to $132000.0 in 2026.
• The last three Other Accumulated Expenses figures came in at $132000.0 (Q1 2026), $267000.0 (Q4 2025), and $201000.0 (Q3 2025), per Business Quant data.